Streetbeat News

Stock Prices

FOR

Forestar Group's stock has been upgraded from Neutral to Buy by BTIG, with a new price target of $32.

Portfolio Pulse from Benzinga Newsdesk

July 21, 2023 | 3:26 pm

RUM

Rumble CEO Chris Pavlovski has tweeted that he is aware of nearly 10 million shares being short on Rumble ($RUM) and has made it his mission to make it difficult for these short sellers.

Portfolio Pulse from Happy Mohamed

July 21, 2023 | 3:24 pm

JPM

A whale investor has taken a bullish stance on JPMorgan Chase (NYSE:JPM), with 50% of the investors opening trades with bullish expectations and 50% with bearish. The whale has been targeting a price range from $85.0 to $160.0 for JPMorgan Chase over the last 3 months. The current price of JPM is down -0.69% at $155.07. RSI indicators suggest that the stock may be overbought. The next earnings are expected to be released in 84 days.

Portfolio Pulse from Benzinga Insights

July 21, 2023 | 3:17 pm

CVS

A significant bearish stance has been taken on CVS Health (NYSE:CVS) by a large investor, as indicated by a large position in options. The sentiment among these big-money traders is 30% bullish and 70% bearish. The targeted price range for CVS Health over the last 3 months is $70.0 to $77.5. The current price of CVS is $75.12, up 0.33%. JP Morgan, Barclays, and Mizuho have maintained their positive ratings on CVS Health, with price targets of $106, $89, and $88 respectively.

Portfolio Pulse from Benzinga Insights

July 21, 2023 | 3:17 pm

QNRX

Quoin Pharmaceuticals, Ltd. (NASDAQ:QNRX) shares are trading higher after the company effected an ADS ratio change equivalent to a 1-for-12 reverse stock split. The stock has been trending on StockTwits and Yahoo! Finance, and trading has been halted multiple times due to heavy volume. More than 1.73 million shares have been traded, far exceeding the QNRX 100-day average of 20.42 thousand shares.

Portfolio Pulse from Erica Kollmann

July 21, 2023 | 3:15 pm

LYV

Shares of Live Nation Entertainment Inc (NYSE:LYV) have climbed more than 40% year to date. Analyst Jed Kelly from Oppenheimer initiated coverage of Live Nation Entertainment with an Outperform rating and a price target of $110. Kelly noted that the company's breadth of inventory is well positioned to deliver more events to a wider network of fans and is likely to benefit from music streaming advancements. Live Nation's proactive partnership with legislators on fair ticketing initiatives is expected to reduce the likelihood of a negative regulatory outcome.

Portfolio Pulse from Priya Nigam

July 21, 2023 | 3:14 pm

SCHL

Scholastic Corporation reported better-than-expected Q4 adjusted EPS results and issued FY24 guidance. The company also approved a $100 million increase in its share repurchase authorization, leading to a rise in its share price.

Portfolio Pulse from Benzinga Newsdesk

July 21, 2023 | 3:14 pm

AMD

NVDA

TSM

AMD is reportedly exploring alternatives to its production and partner foundries to reduce reliance on TSMC. CEO Lisa Su expressed openness to leveraging TSMC sites outside Taiwan and highlighted the significant opportunity in AI with GPUs. BofA analyst Vivek Arya cut his price target for AMD to $130 from $135, citing pressure from NVDA's full-stack AI platform on AMD data center GPU market share.

Portfolio Pulse from Anusuya Lahiri

July 21, 2023 | 3:14 pm

RDHL

Redhill Biopharma has announced a $3.8M registered direct offering of 1,301,923 shares at $1.35 per share, leading to a decrease in its stock price.

Portfolio Pulse from Benzinga Newsdesk

July 21, 2023 | 3:14 pm

AAPL

AVGO

AXP

BTCUSD

QQQ

The Nasdaq 100 is set to undergo a rebalancing, which will see the weight of seven major stocks, including Apple, Microsoft, Alphabet, Amazon, NVIDIA, Meta Platforms, and Tesla, reduced. The change in weight will be distributed to other stocks in the index, with Broadcom, PepsiCo, Costco, Adobe, Cisco Systems, and Netflix among the top beneficiaries. The rebalancing, effective from July 24, is expected to cause volatility, especially as it coincides with $2.4 trillion of options expiration. However, Wall Street consensus suggests buying the 'magnificent seven' stocks on any dip caused by the rebalancing.

Portfolio Pulse from The Arora Report

July 21, 2023 | 3:11 pm